These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 8768271)
21. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study). May HT; Anderson JL; Pearson RR; Jensen JR; Horne BD; Lavasani F; Yannicelli HD; Muhlestein JB Am J Cardiol; 2008 Feb; 101(4):486-9. PubMed ID: 18312763 [TBL] [Abstract][Full Text] [Related]
22. [Secondary prevention of coronary artery disease with lipid-lowering drugs]. Delahaye F; De Gevigney G Ann Med Interne (Paris); 2001 Apr; 152(3):184-7. PubMed ID: 11431578 [TBL] [Abstract][Full Text] [Related]
23. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients. Strony J; Hoffman R; Hanson M; Veltri E Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588 [TBL] [Abstract][Full Text] [Related]
24. Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study. Cheung RC; Morrell JM; Kallend D; Watkins C; Schuster H Int J Cardiol; 2005 Apr; 100(2):309-16. PubMed ID: 15823640 [TBL] [Abstract][Full Text] [Related]
26. HIV protease inhibitors and dyslipidemia. Clotet B; Negredo E AIDS Rev; 2003; 5(1):19-24. PubMed ID: 12875104 [TBL] [Abstract][Full Text] [Related]
27. Management of hypercholesterolaemia in the patient with diabetes. Packard C; Olsson AG Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606 [TBL] [Abstract][Full Text] [Related]
28. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease. Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932 [TBL] [Abstract][Full Text] [Related]
29. Management of patients with dyslipidaemia. Mann J; Chisholm A; Crooke M; Jackson R; Neutze J; North D; Swinburn B; White H; Wilcox J N Z Med J; 1995 Oct; 108(1010):444. PubMed ID: 7478355 [No Abstract] [Full Text] [Related]
30. Treatment of hyperlipidemia after heart transplantation and rationale for the Heart Transplant Lipid Registry. Ballantyne CM; Bourge RC; Domalik LJ; Eisen HJ; Fishbein DP; Kubo SH; Lake KD; Radovancevic B; Taylor DO; Ventura HO; Yancy CW; Young JB Am J Cardiol; 1996 Sep; 78(5):532-5. PubMed ID: 8806337 [TBL] [Abstract][Full Text] [Related]
31. Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety. Shepherd J Eur Heart J; 1995 Jan; 16(1):5-13. PubMed ID: 7737222 [No Abstract] [Full Text] [Related]
32. [Antihyperlipidemic actions in the treatment of nephropathies]. Neverov NI; Tareeva IE; Miroshnichenko NG; Stavrovskaia EV Ter Arkh; 1995; 67(8):15-7. PubMed ID: 7482321 [TBL] [Abstract][Full Text] [Related]